Financial News
Iovance Biotherapeutics Inc (NQ: IOVA )
9.250
-0.180
(-1.91%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 26, 2024
Add to My Watchlist
All News about Iovance Biotherapeutics Inc
![](https://g.foolcdn.com/editorial/images/728782/parabola.jpg)
![](https://g.foolcdn.com/editorial/images/726076/physician-going-over-results-with-patient.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/03/27/stock_chart_higher.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/03/27/image47.jpg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
Analyst Expectations for Iovance Biotherapeutics's Future
March 27, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Expert Ratings for Iovance Biotherapeutics
March 06, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_2017.jpeg?width=1200&height=800&fit=crop)
The Latest Analyst Ratings for Iovance Biotherapeutics
January 24, 2023
Via Benzinga
What 6 Analyst Ratings Have To Say About Iovance Biotherapeutics
December 09, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/03/27/image27.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/03/27/first_republic_bank_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/d0986bd6-4603-4e31-8ed1-f23b3e123605/small/iovance-jpg.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_7957.png?width=1200&height=800&fit=crop)
What 4 Analyst Ratings Have To Say About Iovance Biotherapeutics
November 21, 2022
Via Benzinga
![](https://ml.globenewswire.com/media/d0986bd6-4603-4e31-8ed1-f23b3e123605/small/iovance-jpg.jpg)
Iovance Biotherapeutics to Present at Upcoming Conferences
March 01, 2023
Via GlobeNewswire
![](https://ml.globenewswire.com/media/d0986bd6-4603-4e31-8ed1-f23b3e123605/small/iovance-jpg.jpg)
![](https://ml.globenewswire.com/media/d0986bd6-4603-4e31-8ed1-f23b3e123605/small/iovance-jpg.jpg)
![](/next-assets/images/schema-image-default.png)
Benzinga's Top Ratings Upgrades, Downgrades For January 27, 2023
January 27, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/01/27/image-american_express_0.png?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/717662/person-in-a-lab-looking-through-a-microscope.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/01/23/mark_composite_dark__9bc45f3b0f048b8c13d7471dd651993a.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://ml.globenewswire.com/media/d0986bd6-4603-4e31-8ed1-f23b3e123605/small/iovance-jpg.jpg)
![](https://investorplace.com/wp-content/uploads/2022/10/pill-bottle-biopharma-biotech-1600.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/12/05/image16.jpg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Monday's Intraday Session
December 05, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/12/05/image44.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/12/05/analysis-g91a50a4fe_1920.jpg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Monday's Pre-Market Session
December 05, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/12/05/image19.jpg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/d0986bd6-4603-4e31-8ed1-f23b3e123605/small/iovance-jpg.jpg)
Iovance Biotherapeutics to Present at Upcoming Conferences
November 30, 2022
Via GlobeNewswire
![](https://cdn.benzinga.com/files/images/story/2022/11/21/image-nio.png?width=1200&height=800&fit=crop)
NIO To Surge Around 105%? Plus Keybanc Predicts $165 For This Stock
November 21, 2022
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.